{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:35:21Z","timestamp":1790832921653,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T00:00:00Z","timestamp":1506124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s40618-017-0762-3","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T07:51:27Z","timestamp":1506153087000},"page":"383-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index"],"prefix":"10.1007","volume":"41","author":[{"given":"R. A.","family":"Condorelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Calogero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Di Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Mongioi\u2019","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cannarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"La Vignera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,23]]},"reference":[{"issue":"1","key":"762_CR1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K (2012) Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 97(1):28\u201338","journal-title":"Fertil Steril"},{"issue":"11","key":"762_CR2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society (AES) (2015) American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014part 1. Endocr Pract 21(11):1291\u20131300","journal-title":"Endocr Pract"},{"issue":"5","key":"762_CR3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","volume":"20","author":"JA Barry","year":"2014","unstructured":"Barry JA, Azizia MM, Hardiman PJ (2014) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Updat 20(5):748\u2013758","journal-title":"Hum Reprod Updat"},{"issue":"12","key":"762_CR4","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society (AES) (2015) American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014part 2. Endocr Pract 21(12):1415\u20131426","journal-title":"Endocr Pract"},{"issue":"3","key":"762_CR5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.2003-031205","volume":"89","author":"E Diamanti-Kandarakis","year":"2004","unstructured":"Diamanti-Kandarakis E, Kouli C, Alexandraki K, Spina G (2004) Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. JCEM 89(3):1273\u20131276","journal-title":"JCEM"},{"key":"762_CR6","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","volume":"31","author":"S Cassar","year":"2016","unstructured":"Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK (2016) Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod 31:2619\u20132631","journal-title":"Hum Reprod"},{"key":"762_CR7","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/db11-1360","volume":"61","author":"A Gambieri","year":"2012","unstructured":"Gambieri A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, Pasquali R (2012) Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. Diabetes 61:2369\u20132374","journal-title":"Diabetes"},{"key":"762_CR8","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774\u2013800","journal-title":"Endocr Rev"},{"key":"762_CR9","doi-asserted-by":"crossref","first-page":"E770","DOI":"10.1152\/ajpendo.00510.2014","volume":"308","author":"SK Malin","year":"2015","unstructured":"Malin SK, Kirwan JP, Sia CL, Gonz\u00e0les F (2015) Pancreatic \u03b2-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-kB activation and systemic inflammation. Am J Physiol Endocrinol Metab 308:E770\u2013E777","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"762_CR10","first-page":"1686","volume":"79","author":"RL Rosenfield","year":"1994","unstructured":"Rosenfield RL, Barnes RB, Ehrmann DA (1994) Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. JCEM 79(6):1686\u20131692","journal-title":"JCEM"},{"key":"762_CR11","first-page":"551","volume":"15","author":"Asieh Mansour","year":"2016","unstructured":"Mansour A, Hosseini S, Larijani B, Mohajeri-Tehrani MR (2016) Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome. EXCLI J 15:551\u2013564","journal-title":"EXCLI J"},{"issue":"5","key":"762_CR12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cmet.2016.03.015","volume":"23","author":"G Navarro","year":"2016","unstructured":"Navarro G, Xu W, Jacobson DA, Wicksteed B, Allard C, Zhang G, De Gendt K, Kim SH, Wu H, Zhang H, Verhoeven G, Katzenellenbogen JA, Mauvais-Jarvis F (2016) Extranuclear actions of the androgen receptor enhance glucose-stimulated insulin secretion in the male. Cell Metab 23(5):837\u2013851","journal-title":"Cell Metab"},{"key":"762_CR13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ebiom.2017.01.011","volume":"16","author":"S Tian","year":"2017","unstructured":"Tian S, Lin XH, Xiong YM, Liu ME, Yu TT, Lv M, Zhao W, Xu GF, Ding GL, Xu CM, Jin M, Feng C, Wu YT, Tan YJ, Gao Q, Zhang J, Li C, Ren J, Jin LY, Chen B, Zhu H, Zhang XY, Chen SC, Liu XM, Liu Y, Zhang JY, Wang L, Zhang P, Chen XJ, Jin L, Chen X, Meng YC, Wu DD, Lin H, Yang Q, Zhou CL, Li XZ, Wang YY, Xiang YQ, Liu ZW, Gao L, Chen LT, Pan HJ, Li R, Zhang FH, Xing LF, Zhu YM, Klausen C, Leung PC, Li JX, Sun F, Sheng JZ, Huang HF (2017) Prevalence of prediabetes risk in offspring born to mothers with hyperandrogenism. EBioMedicine 16:275\u2013283","journal-title":"EBioMedicine"},{"issue":"2","key":"762_CR14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.23736\/S0391-1977.16.02564-5","volume":"42","author":"E Makri","year":"2017","unstructured":"Makri E, Tziomalos K (2017) Prevalence, etiology and management of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome. Minerva Endocrinol 42(2):122\u2013131","journal-title":"Minerva Endocrinol"},{"key":"762_CR15","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3748\/wjg.v20.i26.8351","volume":"20","author":"E Vassilatou","year":"2014","unstructured":"Vassilatou E (2014) Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J Gastroenterol 20:8351\u20138363","journal-title":"World J Gastroenterol"},{"key":"762_CR16","doi-asserted-by":"crossref","first-page":"12587","DOI":"10.1073\/pnas.0705408104","volume":"104","author":"KF Petersen","year":"2007","unstructured":"Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S et al (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 104:12587\u201312594","journal-title":"Proc Natl Acad Sci USA"},{"key":"762_CR17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.nutr.012809.104726","volume":"30","author":"FR Jornayvaz","year":"2010","unstructured":"Jornayvaz FR, Samuel VT, Shulman GI (2010) The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and non-alcoholic fatty liver disease associated with the metabolic syndrome. Annu Rev Nutr 30:273\u2013290","journal-title":"Annu Rev Nutr"},{"key":"762_CR18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1479-5876-11-133","volume":"11","author":"A Baranova","year":"2013","unstructured":"Baranova A, Tran TP, Afendy A, Wang L, Shamsaddini A, Mehta R et al (2013) Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS). J Transl Med 11:133","journal-title":"J Transl Med"},{"key":"762_CR19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/humrep\/dew076","volume":"31","author":"D Macut","year":"2016","unstructured":"Macut D, Tziomalos K, Bo\u017ei\u0107-Anti\u0107 I, Bjeki\u0107-Macut J, Katsikis I, Papadakis E et al (2016) Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome. Hum Reprod 31:1347\u20131353","journal-title":"Hum Reprod"},{"key":"762_CR20","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/endo.138.9.5404","volume":"138","author":"GE Croston","year":"1997","unstructured":"Croston GE, Milan LB, Marschke KB, Reichman M, Briggs MR (1997) Androgen receptor-mediated antagonism of estrogen-dependent low density lipoprotein receptor transcription in cultured hepatocytes. Endocrinology 138:3779\u20133786","journal-title":"Endocrinology"},{"key":"762_CR21","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2009-2698","volume":"95","author":"MJ Chen","year":"2010","unstructured":"Chen MJ, Chiu HM, Chen CL, Yang WS, Yang YS, Ho HN (2010) Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome. JCEM 95:3332\u20133341","journal-title":"JCEM"},{"key":"762_CR22","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","volume":"97","author":"H Jones","year":"2012","unstructured":"Jones H, Sprung VS, Pugh CJ, Daousi C, Irwin A, Aziz N et al (2012) Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. JCEM 97:3709\u20133716","journal-title":"JCEM"},{"issue":"1","key":"762_CR23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/JOE-15-0471","volume":"230","author":"GA Abruzzese","year":"2016","unstructured":"Abruzzese GA, Heber MF, Ferreira SR, Velez LM, Reynoso R, Pignataro OP, Motta AB (2016) Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism. J Endocrinol 230(1):67\u201379","journal-title":"J Endocrinol"},{"key":"762_CR24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","volume":"65","author":"A Dunaif","year":"1987","unstructured":"Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia. JCEM 65:499\u2013507","journal-title":"JCEM"},{"key":"762_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1993.tb02376.x","volume":"39","author":"S Robinson","year":"1993","unstructured":"Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A et al (1993) The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf) 39:351\u2013355","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"36","key":"762_CR26","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.2174\/1381612822666160726103133","volume":"22","author":"GK Dimitriadis","year":"2016","unstructured":"Dimitriadis GK, Kyrou I, Randeva HS (2016) Polycystic ovary syndrome as a proinflammatory state: the role of adipokines. Curr Pharm Des 22(36):5535\u20135546","journal-title":"Curr Pharm Des"},{"key":"762_CR27","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1210\/jc.2010-1290","volume":"96","author":"L Manner\u00e5s-Holm","year":"2011","unstructured":"Manner\u00e5s-Holm L, Leonhardt H, Kullberg J et al (2011) Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. JCEM 96:E304\u2013E311","journal-title":"JCEM"},{"key":"762_CR28","doi-asserted-by":"crossref","first-page":"E1756","DOI":"10.1210\/jc.2011-0615","volume":"96","author":"T McLaughlin","year":"2011","unstructured":"McLaughlin T, Lamendola C, Liu A, Abbasi F (2011) Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. JCEM 96:E1756\u2013E1760","journal-title":"JCEM"},{"issue":"11","key":"762_CR29","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/jc.2016-2586","volume":"101","author":"DA Dumesic","year":"2016","unstructured":"Dumesic DA, Akopians AL, Madrigal VK, Ramirez E, Margolis DJ, Sarma MK, Thomas AM, Grogan TR, Haykal R, Schooler TA, Okeya BL, Abbott DH, Chazenbalk GD (2016) Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. JCEM 101(11):4178\u20134188","journal-title":"JCEM"},{"issue":"5","key":"762_CR30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40618-015-0403-7","volume":"39","author":"H Li","year":"2016","unstructured":"Li H, Xu X, Wang X, Liao X, Li L, Yang G, Gao L (2016) Free androgen index and Irisin in polycystic ovary syndrome. J Endocrinol Invest 39(5):549\u2013556","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"762_CR31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40618-016-0570-1","volume":"40","author":"FM Mario","year":"2017","unstructured":"Mario FM, Graff SK, Spritzer PM (2017) Habitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional study. J Endocrinol Invest 40(4):377\u2013384","journal-title":"J Endocrinol Invest"},{"key":"762_CR32","first-page":"952","volume":"81","author":"P Moghetti","year":"1996","unstructured":"Moghetti P, Tosi F, Castello R et al (1996) The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. JCEM 81:952\u2013960","journal-title":"JCEM"},{"key":"762_CR33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cen.12086","volume":"78","author":"IR Wallace","year":"2013","unstructured":"Wallace IR, McKinley MC, Bell PM, Hunter SJ (2013) Sex hormone binding globulin and insulin resistance. Clin Endocrinol (Oxf) 78:321\u2013329","journal-title":"Clin Endocrinol (Oxf)"},{"key":"762_CR34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tem.2011.09.005","volume":"23","author":"TN Le","year":"2012","unstructured":"Le TN, Nestler JE, Strauss JF 3rd, Wickam EP 3rd (2012) Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab 23:32\u201340","journal-title":"Trends Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-017-0762-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0762-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0762-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T08:00:47Z","timestamp":1659513647000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-017-0762-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,23]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1007\/s40618-017-0762-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,23]]}}}